ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628297 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628297; 2) Community: the network communities that were significantly associated with the response to NSC 628297; 3) Molecule: the relationships between components within communities and NSC 628297; 4) MDR: the compounds that were significantly associated with the NSC 628297.

NSC Compound Enrichment Correlation
NSC 722877 Null 0.00479683626511392 0.13034758
NSC 724058 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00479683626511392 0.19462349
NSC 92915 ANTINEOPLASTIC-92915 0.00479683626511392 0.29878232
NSC 94037 Mikanolide 0.00479683626511392 0.28065391
NSC 102225 Null 0.0048681766467277 0.1670587
NSC 105132 Deoxycamptothecin 0.0048681766467277 0.093631961
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0048681766467277 0.20864159
NSC 357777 Null 0.0048681766467277 0.1166846
NSC 382032 Null 0.0048681766467277 0.18746522
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.0048681766467277 0.30161301
Total:126  Current:20    [First] [Prev] [Next] [Last]